Skip to content

ED Lung Protective Ventilation to Reduce Complications

The Effect of Lung Protective Ventilation Initiated in the Emergency Department on the Incidence of Pulmonary Complications and Clinical Outcomes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02543554
Enrollment
1705
Registered
2015-09-07
Start date
2014-10-31
Completion date
2016-03-31
Last updated
2018-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mechanical Ventilation, Ventilator-associated Conditions, ARDS

Brief summary

Early mechanical ventilation, if delivered with injurious settings, can lead to pulmonary complications, such as acute respiratory distress syndrome (ARDS). Mechanical ventilation in the emergency department (ED) has been studied infrequently when compared to the intensive care unit; however, data suggests that ED-based mechanical ventilation has significant room for improvement and may also be a causative factor in ARDS incidence.

Detailed description

This is a before-after study examining the impact of implementing lung protective ventilation in the emergency department.

Interventions

Lung protective ventilation strategy, which aims to deliver safe tidal volumes, appropriate PEEP, limit plateau pressure, and limit hyperoxia.

Sponsors

Washington University School of Medicine
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* mechanically ventilated via an endotracheal tube in the ED

Exclusion criteria

* death in the ED, * death or discontinuation of ventilation within 24 hours, * chronic mechanical ventilation, * ARDS while in the ED * transfer to another hospital.

Design outcomes

Primary

MeasureTime frame
Number of Patients That Experience Pulmonary Complications After Admission From the Emergency Department7 days

Secondary

MeasureTime frame
Number of Patients That Die During the HospitalizationPatients will be followed for the duration of hospital stay

Countries

United States

Participant flow

Participants by arm

ArmCount
Pre-intervention Group
mechanically ventilated patients before implementation of ED lung protective ventilation
1,192
Intervention Group
mechanically ventilated patients after implementation of ED lung protective ventilation lung protective ventilation: Lung protective ventilation strategy, which aims to deliver safe tidal volumes, appropriate PEEP, limit plateau pressure, and limit hyperoxia.
513
Total1,705

Baseline characteristics

CharacteristicIntervention GroupPre-intervention GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
156 Participants438 Participants594 Participants
Age, Categorical
Between 18 and 65 years
357 Participants754 Participants1111 Participants
Age, Continuous58.0 years
STANDARD_DEVIATION 24
60.4 years
STANDARD_DEVIATION 21.1
58.8 years
STANDARD_DEVIATION 16.9
Region of Enrollment
United States
513 participants1192 participants1705 participants
Sex: Female, Male
Female
210 Participants564 Participants774 Participants
Sex: Female, Male
Male
303 Participants628 Participants931 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1,1920 / 513
serious
Total, serious adverse events
0 / 1,1920 / 513

Outcome results

Primary

Number of Patients That Experience Pulmonary Complications After Admission From the Emergency Department

Time frame: 7 days

ArmMeasureValue (NUMBER)
Pre-intervention GroupNumber of Patients That Experience Pulmonary Complications After Admission From the Emergency Department171 participants
Intervention GroupNumber of Patients That Experience Pulmonary Complications After Admission From the Emergency Department38 participants
Secondary

Number of Patients That Die During the Hospitalization

Time frame: Patients will be followed for the duration of hospital stay

ArmMeasureValue (NUMBER)
Pre-intervention GroupNumber of Patients That Die During the Hospitalization338 participants
Intervention GroupNumber of Patients That Die During the Hospitalization105 participants

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026